The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Artificial Implants in US$ Million by the following Segments: Orthopedic Implants (Spinal Implants, Hip Implants, Knee Implants, & Extremities Implants), Dental Implants, Cardiac Implants, and Cochlear Implants.
Company profiles are primarily based on public domain information including company URLs. The report profiles 242 companies including many key and niche players such as -
Abiomed, Inc. (USA)
Bicon, LLC (USA)
Biotronik SE & Co. KG (Germany)
Boston Scientific Corporation (USA)
Cochlear Limited (Australia)
Dentsply Sirona (USA)
DePuy Synthes Companies (USA)
Exactech Inc. (USA)
GS Medical LLC (USA)
Institut Straumann AG (Switzerland)
Integra Lifesciences Holdings Corporation (USA)
Japan Medical Dynamic Marketing Inc. (Japan)
MED-EL Medical Electronics (Austria)
Medtronic plc (Ireland)
Nobel Biocare Services AG (Sweden)
RTI Surgical, Inc. (USA)
Showa Ika Kohgyo Co., Ltd (Japan)
Smith & Nephew Plc (UK)
St. Jude Medical, Inc. (USA)
Sonova Holding AG (Switzerland)
Advanced Bionics Corporation (USA)
Stryker Corporation (USA)
TTK Healthcare, Ltd. (India)
Terumo Corporation (Japan)
Wright Medical Group N.V. (Netherlands)
Zimmer Biomet Holdings, Inc. (USA)
Biomet 3i, Inc. (USA)
Key Topics Covered:
1. INDUSTRY OVERVIEW
Artificial Implants on High Growth Trajectory
Current & Future Analysis
Demand Determinants
Developed Markets Stabilize
Emerging Markets to the Fore
2. ORTHOPEDIC IMPLANTS
3. DENTAL IMPLANTS
4. CARDIAC IMPLANTS
5. COCHLEAR IMPLANTS
6. PRODUCT OVERVIEW
7. PRODUCT INNOVATIONS/APPROVALS
Rodo Medical's Rodo Abutment System Receives FDA Clearance
Abiomed Receives FDA Pre-Market Approval for Expanded Indication of Impella Heart Pump
Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively.
CancerVision and...
PossibleNOWtm, the leading provider of enterprise consent and preference management solutions, today announced the launch of a program to enable companies to quickly capture express written consent. This will provide the ability for Third-Party...
Envisagenics, an AI-driven biotechnology company, today announced the publication in the journal Molecular Systems Biology of study results evaluating the company's SpliceCore AI/ML platform in Triple Negative Breast Cancer (TNBC). This study...
Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the...
Coronis Health, a trusted partner for laboratory and pathology revenue cycle management (RCM), will be a leading voice at the upcoming Executive War College (EWC) 2024 conference from April 30 to May 1 in New Orleans. As the premier forum for...
PRUVN Research LLC, [PRUVN], a leading research organization validating wellness products and services, is excited to announce the results of its recent preliminary study with Max International, investigating the impact of RiboCeinetm supplementation...